Frontlight ResearchEarly access
Trial site
University Hospital Of North Norway HF
- 10running trials
- 6closed trials
The trials here
What the 16 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Acute myeloid leukaemia2 trials
- Childhood cancers2 trials
- Endometrial cancer2 trials
- Myelodysplastic syndromes2 trials
- Acute lymphoblastic leukaemia1 trial
- Atopic dermatitis (eczema)1 trial
- Atrial fibrillation1 trial
- Chronic kidney disease1 trial
- Colorectal cancer1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Immune thrombocytopenia (ITP)1 trial
- and 5 more
- Phase
- Phase 39 trials
- Phase 25 trials
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Active, not recruiting7 trials
- Completed6 trials
- Recruiting3 trials
- Lead sponsor
- Merck Sharp & Dohme LLC2 trials
- Stichting Hemato-Oncologie voor Volwassenen Nederland2 trials
- AbbVie1 trial
- Arctic Bioscience AS1 trial
- AstraZeneca1 trial
- and 9 more
Running trials
Recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
METIMMOX-2: Metastatic pMMR/MSS Colorectal Cancer - Shaping Anti-Tumor Immunity by Oxaliplatin
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute lymphoblastic leukaemia1 recruiting
- Atrial fibrillation1 recruiting
- Childhood cancers1 recruiting
- Chronic kidney disease1 recruiting
- Immune thrombocytopenia (ITP)1 recruiting
Closed trials
Completed
Completed
Completed
A Study in Participants With Non-cirrhotic NASH With Fibrosis
Recruiting
Active, not recruiting
Active, not recruiting
Site data: EU CTIS (euclinicaltrials.eu)Updated 13 Nov 2026